| Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and … AHEM Maas, G Rosano, R Cifkova, A Chieffo, D van Dijken, H Hamoda, ... European Heart Journal 42 (10), 967-984, 2021 | 301 | 2021 |
| A randomized trial of endometrial scratching before in vitro fertilization S Lensen, D Osavlyuk, S Armstrong, C Stadelmann, A Hennes, E Napier, ... New England Journal of Medicine 380 (4), 325-334, 2019 | 210 | 2019 |
| The 2013 British menopause society & women’s health concern recommendations on hormone replacement therapy N Panay, H Hamoda, R Arya, M Savvas Menopause international 19 (2), 59-68, 2013 | 210 | 2013 |
| The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women H Hamoda, N Panay, H Pedder, R Arya, M Savvas Post reproductive health 26 (4), 181-209, 2020 | 142 | 2020 |
| Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis C Achilli, J Pundir, P Ramanathan, L Sabatini, H Hamoda, N Panay Fertility and sterility 107 (2), 475-482. e15, 2017 | 140 | 2017 |
| Oogenesis and cell death in human prenatal ovaries: what are the criteria for oocyte selection? GM Hartshorne, S Lyrakou, H Hamoda, E Oloto, F Ghafari Molecular human reproduction 15 (12), 805-819, 2009 | 129 | 2009 |
| A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception H Hamoda, PW Ashok, C Stalder, GMM Flett, E Kennedy, A Templeton Obstetrics & Gynecology 104 (6), 1307-1313, 2004 | 119 | 2004 |
| The British Menopause Society and Women’s Health Concern recommendations on the management of women with premature ovarian insufficiency H Hamoda Post Reproductive Health 23 (1), 22-35, 2017 | 112 | 2017 |
| A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation H Hamoda, PW Ashok, GMM Flett, A Templeton Human Reproduction 20 (8), 2348-2354, 2005 | 111 | 2005 |
| A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation H Hamoda, PW Ashok, GMM Flett, A Templeton BJOG: An International Journal of Obstetrics & Gynaecology 112 (8), 1102-1108, 2005 | 103 | 2005 |
| Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation H Hamoda, PW Ashok, GMM Flett, A Templeton BJOG: An International Journal of Obstetrics & Gynaecology 111 (9), 996-1000, 2004 | 88 | 2004 |
| Medical abortion at 9–13 weeks' gestation: a review of 1076 consecutive cases H Hamoda, PW Ashok, GMM Flett, A Templeton Contraception 71 (5), 327-332, 2005 | 83 | 2005 |
| Hormone replacement therapy–Current recommendations K Vigneswaran, H Hamoda Best practice & research Clinical obstetrics & gynaecology 81, 8-21, 2022 | 78 | 2022 |
| A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion H Hamoda, PW Ashok, GMM Flett, A Templeton American journal of obstetrics and gynecology 190 (1), 55-59, 2004 | 76 | 2004 |
| Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society I Lambrinoudaki, E Armeni, D Goulis, S Bretz, I Ceausu, F Durmusoglu, ... Maturitas 163, 1-14, 2022 | 75 | 2022 |
| The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement M Rees, K Abernethy, G Bachmann, S Bretz, I Ceausu, F Durmusoglu, ... Maturitas 158, 70-77, 2022 | 66 | 2022 |
| The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women H Hamoda, N Panay, R Arya, M Savvas, ... Post Reproductive Health 22 (4), 165-183, 2016 | 64 | 2016 |
| Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis S Seshadri, SK Sunkara, Y Khalaf, T El-Toukhy, H Hamoda Reproductive Biomedicine Online 25 (6), 572-584, 2012 | 63 | 2012 |
| Medical and surgical options for induced abortion in first trimester H Hamoda, A Templeton Best practice & research Clinical obstetrics & gynaecology 24 (4), 503-516, 2010 | 63 | 2010 |
| A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation H Hamoda, PW Ashok, J Dow, GMM Flett, A Templeton Contraception 68 (5), 335-338, 2003 | 60 | 2003 |
